Ropes & Gray has advised Sanofi.Sanofi has entered into a collaboration and global license agreement with EVOQ Therapeutics to develop therapies for autoimmune diseases using EVOQ’s…
Sanofi and EVOQ Therapeutics Sign $500 Million Collaboration and Licensing Agreement

























